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In Brief Fossati et al. show that, in stark contrast to other iGluRs, the glutamate receptor delta-1 (GluD1) operates at inhibitory, rather than excitatory, synapses in the cortex. GluD1 mediates trans-synaptic signaling governing the formation of synapses between specific interneurons and pyramidal neurons.
SUMMARY
Fine orchestration of excitatory and inhibitory synaptic development is required for normal brain function, and alterations may cause neurodevelopmental disorders. Using sparse molecular manipulations in intact brain circuits, we show that the glutamate receptor delta-1 (GluD1), a member of ionotropic glutamate receptors (iGluRs), is a postsynaptic organizer of inhibitory synapses in cortical pyramidal neurons. GluD1 is selectively required for the formation of inhibitory synapses and regulates GABAergic synaptic transmission accordingly. At inhibitory synapses, GluD1 interacts with cerebellin-4, an extracellular scaffolding protein secreted by somatostatin-expressing interneurons, which bridges postsynaptic GluD1 and presynaptic neurexins. When binding to its agonist glycine or D-serine, GluD1 elicits non-ionotropic postsynaptic signaling involving the guanine nucleotide exchange factor ARHGEF12 and the regulatory subunit of protein phosphatase 1 PPP1R12A. Thus, GluD1 defines a trans-synaptic interaction regulating postsynaptic signaling pathways for the proper establishment of cortical inhibitory connectivity and challenges the dichotomy between iGluRs and inhibitory synaptic molecules.
INTRODUCTION
Synapses constitute the elementary functional units of the brain. They convey excitatory or inhibitory signals that need to be coordinated in space and time for optimal brain function (Mullins et al., 2016; Nelson and Valakh, 2015) . Excitatory and inhibitory synapses in the mammalian brain mainly use glutamate and gamma-aminobutyric acid (GABA) as a neurotransmitter, respectively. They are multi-molecular nanomachines composed of almost exclusive sets of proteins (Krueger-Burg et al., 2017; Sheng and Kim, 2011; Tyagarajan and Fritschy, 2014 ). Yet they share the same basic organization, which ensures the efficacy and fine-tuning of synaptic transmission. The organization of synapses relies on transient, highly regulated interactions between various categories of proteins (neurotransmitter receptors, scaffolding proteins, adhesion proteins, signaling molecules, and cytoskeleton elements) and accommodates a great level of molecular diversity (Choquet and Triller, 2013; Emes and Grant, 2012; Sheng and Hoogenraad, 2007; Tyagarajan and Fritschy, 2014; Ziv and Fisher-Lavie, 2014) . The molecular diversity of synapses enables the establishment of complex neuronal networks: it specifies their functional properties and shapes the transfer of information between neurons throughout the brain. Hence, synaptic dysfunctions cause a wide range of neurodevelopmental and psychiatric disorders, such as epilepsy, autisms, or schizophrenia (Bourgeron, 2015; Mullins et al., 2016; Nelson and Valakh, 2015; Ting et al., 2012; Zoghbi and Bear, 2012) . Trans-synaptic molecular interactions critically contribute to both the development and diversification of synaptic connections. They instruct the formation of synapses following initial contact (McAllister, 2007; Missler et al., 2012) , match pre-and post-synaptic neurons (Berns et al., 2018; de Wit and Ghosh, 2016) , control the recruitment of neurotransmitter receptors and postsynaptic scaffolding proteins (Aoto et al., 2013; Bemben et al., 2015; Fukata et al., 2006; Lovero et al., 2015; Mondin et al., 2011; Nam and Chen, 2005; Poulopoulos et al., 2009) , and regulate synaptic plasticity (Bemben et al., 2015; Jang et al., 2017; Tai et al., 2008; Yuzaki and Aricescu, 2017) . Nonetheless, frequent discrepancies between in vitro and in vivo studies have made the role of some trans-synaptic molecular interactions difficult to precisely delineate. Furthermore, the scarcity of information on how trans-synaptic signals are transduced in the post-synaptic neuron stymies our understanding of the molecular logic governing the assembly of synaptic connections.
Individual synaptic proteins may operate through a diversity of modalities. Recently, it has emerged that ionotropic glutamate receptors (iGluRs), which are the main excitatory neurotransmitter receptors in the CNS, do not solely operate through ionotropic mechanisms (Dore et al., 2015; Rodríguez-Moreno and Sihra, 2007; Yuzaki and Aricescu, 2017) . At least some iGluRs engage in trans-synaptic interactions along with conventional cell adhesion molecules (CAMs) (Matsuda et al., 2010 Uemura et al., 2010) or mediate non-ionotropic signaling critical for synaptic development and plasticity (Babiec et al., 2014; Carter and Jahr, 2016; Dore et al., 2015; Grabauskas et al., 2007; Hayashi et al., 1999; Kakegawa et al., 2011; Lerma and Marques, 2013; Nabavi et al., 2013; Saglietti et al., 2007; Stein et al., 2015) . Alternative functions of iGluRs are best characterized for the glutamate receptor delta-2 (GluD2), an iGluR of the delta subfamily (comprising GluD1 and GluD2 receptor subunits, encoded by the genes grid1 and grid2) predominantly expressed in the cerebellum (Araki et al., 1993) . GluD2 is confined in the postsynaptic membrane of excitatory synapses between parallel fibers (PFs) and Purkinje cells (PCs). It contributes to synaptic adhesion by interacting with presynaptic neurexins containing an insert in the splice site 4 through the extracellular scaffolding proteins cerebellins (Cblns), presynaptically secreted molecules that belong to the C1q family of the classical complement pathway (S€ udhof, 2017; Uemura et al., 2010; Yuzaki, 2017 Yuzaki, , 2018 . This trans-synaptic interaction controls the specification and maintenance of PF-PC synapses. In addition, activation of GluD2 by its agonist initiates signaling cascades regulating the local accumulation of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and long-term depression (Kakegawa et al., 2011; Yuzaki and Aricescu, 2017) . GluD1 can also form triads with Cblns and neurexins (Yasumura et al., 2012; Yuzaki and Aricescu, 2017) . It is widely expressed in the neocortex, hippocampus, striatum, and cerebellum, where its expression is strongly upregulated during the period of synaptogenesis and remains high in adults (Hepp et al., 2015; Konno et al., 2014) . GluD1 has been implicated in the formation of excitatory synapses in the cerebellum (Konno et al., 2014) and hippocampus (Tao et al., 2018) and in pruning in the hippocampus and medial prefontal cortex (Gupta et al., 2015) . Other studies have suggested a role in the firing of dopaminergic neurons or at inhibitory synapses Ryu et al., 2012; Yasumura et al., 2012) . Notwithstanding, GluD1 function remains poorly understood.
In the present study, we have investigated the role of GluD1 in the development of excitatory and inhibitory synapses in the somato-sensory cortex. By depleting GluD1 in vivo in a few layer 2/3 cortical pyramidal neurons (CPNs) using sparse in utero electroporation (IUE), we demonstrate that GluD1 regulates the formation of inhibitory synapses in dendrites as well as inhibitory synaptic transmission. In contrast, GluD1 is dispensable for the formation and maintenance of excitatory synapses in CNPs. Using an in vivo structure/function analysis, we demonstrate that the regulation of inhibitory synapses by GluD1 requires transsynaptic interaction via Cbln4, an extracellular scaffolding protein secreted by somatostatin-expressing (SST + ) interneurons (INs) (Favuzzi et al., 2019) , activation of the receptor by its endogenous agonists glycine and D-Serine, and post-synaptic signaling via the intracellular C-terminal tail of the receptor. Using mass spectrometry, we characterize GluD1 interactome in developing synapses. We show that GluD1 serves as a hub for molecules implicated in inhibitory synaptogenesis, and we identify two major partners of GluD1, the signaling molecules rho guanine nucleotide exchange factor 12 (ARHGEF12) and protein phosphatase 1 regulatory subunit 12A (PPP1R12A), as critical regulators of inhibitory synapse formation in CPNs. Together, our results define a trans-synaptic signaling pathway centered on an atypical iGluR for the formation and specification of cortical inhibitory circuits.
RESULTS

GluD1 Is Selectively Required for the Formation of Inhibitory Synapses
In order to assess the role of GluD1 in synaptic development, we used cortex-directed IUE at embryonic day (E)15.5. IUE at E15.5 allows the sparse and specific modification of layer 2/3 CPNs in their intact environment and the dissection of cell autonomous mechanisms operating at synapses in vivo ( Figure 1A ). We analyzed the consequences of GluD1 depletion or overexpression on excitatory and inhibitory synapses formed on oblique apical dendrites of layer 2/3 CPNs of the somato-sensory cortex using a morphometric approach ( Figure 1A) . We first used dendritic spines, the postsynaptic site of the majority of excitatory synaptic inputs in the brain (Bourne and Harris, 2008; Yuste, 2013) , and clusters of PSD-95, a major scaffolding protein of excitatory synapses (Sheng and Hoogenraad, 2007) , as a proxy for excitatory synapses ( Figure 1B ). We found that GluD1 depletion using short hairpin RNAs (shRNAs) (shGluD1; Figure S1A ) did not affect the density of dendritric spines in juvenile (postnatal day [P]20-22) or adult (P > 69) mice (102% ± 3% and 105% ± 5% of control in juvenile and adult neurons respectively; Figures 1B-1D) or the density of endogenous PSD-95 clusters visualized using EGFP-tagged fibronectin intrabodies generated with mRNA display (FingR) (Gross et al., 2013) (94% ± 5% of control; Figures 1E and 1F ). GluD1 overexpression, however, decreased spine density to 75% ± 4% of the control value (Figures 1B and 1C) . These results suggest that GluD1 is not necessary for the formation or maintenance of excitatory synapses in layer 2/3 CPNs, though GluD1 may constrain their number if upregulated.
We then assessed the role of GluD1 at inhibitory synapses. To that aim, we expressed small amounts of fluorescent (EGFPtagged) gephyrin ( Figure 1A) , the core component of inhibitory postsynaptic scaffolds (Krueger-Burg et al., 2017; Tyagarajan and Fritschy, 2014) . This approach has been shown to reliably label inhibitory synaptic contacts without affecting synaptic development or inhibitory neurotransmission (Chen et al., 2012; Fossati et al., 2016; van Versendaal et al., 2012) . In juvenile mice, GluD1 knockdown (KD) using shRNAs decreased the density of gephyrin clusters compared to control neurons (77% ± 4% of control; Figures 1G and 1H ; Figure S2 ). Normal gephyrin cluster density was rescued by co-electroporating shGluD1 with a KD-resistant GluD1 construct (GluD1*; Figures 1G and 1H; Figure S1A ). Remarkably, the decrease in gephyrin cluster density induced by GluD1 KD was maintained in adults (79% ± 4% of control; Figure 1I ), indicating that the loss of inhibitory synapses was not compensated over time. To further substantiate the role of GluD1 at inhibitory synapses, we knocked out grid1 in single cells using the CRISPR-Cas9 system. We expressed the enhanced specificity espCas9(1.1) (Slaymaker et al., 2016) and a combination of two guide RNAs (gRNAs) using IUE. In grid1 knockout (KO) neurons, the density of gephyrin clusters was decreased by 22% ± 5% compared to control neurons expressing espCas9(1.1) with mismatched gRNAs (Figures 1J and 1K) , which is consistent with GluD1 KD experiments with shRNAs. In line with these results, GluD1 overexpression increased the density of gephyrin clusters along dendrites by 33% ± 4% ( Figures 1J and 1K) .
To test the physiological consequences of GluD1 inactivation on synaptic transmission, we performed whole- cell patch-clamp recording in electroporated GluD1-depleted neurons and in neighboring non-electroporated control neurons ( Figure 2A ). We compared miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs, respectively) in brain slices from juvenile mice ( Figure 2B ). In line with the morphological data, GluD1 KD did not affect the amplitude or the frequency of mEPSCs (98% ± 8% and 100% ± 4% of control, respectively) ( Figures 2B-2D ). In contrast, GluD1 KD slightly increased the amplitude of mIPSCs and decreased their frequency by z35% ( Figures 2B, 2E , and 2F), which is consistent with the reduced gephyrin cluster density observed in the oblique dendrites of GluD1 KD and KO neurons. We conclude that GluD1 in CPNs is selectively required for the formation of inhibitory synapses. It regulates both the assembly of the gephyrin-based postsynaptic scaffold and inhibitory synaptic transmission.
GluD1 Localizes to Inhibitory Postsynaptic Sites
It is unexpected for a member of the iGluR family to control the formation of inhibitory synapses. Therefore, we asked whether GluD1 accumulates at inhibitory synapses. To answer this question, we performed immunohistochemistry in brain slices from juvenile mice. GluD1 fluorescent puncta were frequently associated with gephyrin clusters in the upper layers of the so-mato-sensory cortex ( Figure 3A ). To determine the precise subcellular localization of GluD1, we employed immuno-electron microscopy (EM). In cortical layer 2/3, inhibitory synapses represent only 10% of the total number of synapses, and they are ''symmetrical'' when observed in EM, meaning that they do not show the electron-dense post-synaptic differentiation facilitating the detection of excitatory synapses. To unambiguously identify inhibitory synapses, we performed double immunostaining of the vesicular GABA transporter (VGAT) and GluD1 ( Figure 3B ). We used diaminobenzidine (DAB) to reveal VGAT. DAB oxidation forms electron-dense precipitates that largely stained VGAT-positive inhibitory presynaptic terminals.
To visualize and precisely localize GluD1 in cortical tissue, we used nanogold particles and silver enhancement. Nanogold particles corresponding to GluD1 were detected in front of VGAT-positive presynaptic terminals and in intracellular compartments in dendrites ( Figure 3B ). Within synapses, GluD1 was frequently observed in postsynaptic membrane domains located at the edge or in the periphery of the active zone, which is consistent with the distribution profile of other synaptic adhesion molecules (Triller and Choquet, 2003; Uchida et al., 1996) . To quantify the proportion of synapses containing GluD1, we electroporated mOrange-tagged GluD1 together with EGFP-tagged GPHN or PSD95 FingRs and a soluble blue fluorescent protein to visualize neuronal morphology (Figure 3C , blue filler not shown). In oblique apical dendrites of layer 2/3 CPNs, z50% of inhibitory synapses contained GluD1 ( Figure 3D ). In contrast, GluD1 was rarely associated with excitatory synapses (21% ± 2%) ( Figure 3D ). Collectively, these results demonstrate the presence of GluD1 at inhibitory synapses and indicate that GluD1 directly operates at inhibitory synapses. 
Inhibitory Synapse Formation Requires GluD1 Binding to Cbln and Activation by Glycine or D-Serine
To determine the molecular basis for GluD1-mediated regulation of inhibitory synapses, we took advantage of the recent crystallographic analysis of the interactions between GluD, Cbln, and neurexin and the abundant literature on the structure/function of GluD2 (Cheng et al., 2016; Elegheert et al., 2016; Kakegawa et al., 2007 Kakegawa et al., , 2009 Kuroyanagi and Hirano, 2010; Yuzaki and Aricescu, 2017) . GluDs, as all members of the iGluR family, are tetrameric receptors (Traynelis et al., 2010) . Each subunit has a modular architecture. The extracellular region contains a distal N-terminal domain (NTD), followed by an agonist-binding domain (ABD). The NTD of the GluD receptor interacts with the extracellular scaffolding protein Cbln (Matsuda et al., 2010; Uemura et al., 2010) , and their ABD binds to glycine and D-serine (but not glutamate) (Naur et al., 2007) , as in some N-methyl-D-aspartate (NMDA) receptor subunits (Paoletti et al., 2013) . The transmembrane domain (TMD) lines the pore of the ion channel. Finally, GluDs contain a C-terminal cytoplasmic domain (CTD) regulating their trafficking and intracellular interactions (Kakegawa et al., 2008; Kohda et al., 2013) . To assay the functional importance of known domains or molecular interactions, we generated key mutant forms of GluD1 ( Figure 4B ). We then used an in utero gene replacement strategy to inactivate endogenous grid1 with shRNAs and replace it with individual mutant forms in vivo and throughout development . This strategy prevents the formation of heteromers between wild-type and mutant subunits of GluD1, which could mask or attenuate some phenotypes. Importantly, all mutants were properly trafficked to the cell surface ( Figure S3A ).
We first examined whether GluD1 function involves trans-synaptic interaction via Cbln. To that aim, we replaced endogenous GluD1 with a DNTD mutant lacking the whole NTD. In juvenile mice, gephyrin cluster density in neurons expressing this mutant was lower than in control (65% ± 4% of control), suggesting that the NTD is critical for GuD1 function (Figures 4A and 4C ). We then specifically disrupted GluD1 interaction with Cbln by introducing two point mutations in the NTD (R341A/W343A, Figure S3B ; residues corresponding to R345 and W347 in GluD2; Elegheert et al., 2016) . Replacement of GluD1 with the R341A/ W343A mutant also led to a lower density of gephyrin clusters (69% ± 4% of control; Figures 4A and 4C) , indicating that GluD1 interaction with the extracellular scaffolding protein Cbln is required for inhibitory synapse formation. Next, we tested whether the regulation of inhibitory synapses requires GluD1 gating by glycine/D-serine, ion-flux through GluD1 channel, and signaling via the CTD of the receptor. Replacement of GluD1 with a mutant containing an arginine to lysine substitution at position 526, which abolishes the affinity for glycine or Dserine (R526K mutant corresponding to position 530 in GluD2) (Kakegawa et al., 2009 (Kakegawa et al., , 2011 Naur et al., 2007) , decreased the density of gephyrin clusters (71% ± 4% of control; Figures 4A  and 4C ), as observed after GluD1 KD. A similar effect was found with a mutant lacking the intracellular CTD (75% ± 5% of control; Figures 4A and 4C) . In contrast, preventing ion flux through the pore with a single point mutation (V617R) (Ady et al., 2014; Kakegawa et al., 2007; Robert et al., 2002) did not interfere with the formation of inhibitory synapses (Figures 4A and 4C) . Collectively, these results demonstrate that the control of inhibitory synapse formation by GluD1 in CPNs requires trans-synaptic interactions via Cbln and glycine/D-serine-dependent non-ionotropic postsynaptic mechanisms involving intracellular interactions via the C-terminal tail of the receptor.
GluD1 Specifies Synapses between SST + INs and Layer 2/3 CPNs
We wondered if GluD1 mediates the formation of inhibitory synapses between layer 2/3 CPNs and specific classes of INs. In the cortex, distinct subtypes of INs express distinct isoforms of Cblns, with SST + INs in upper cortical layers expressing Cbln4 and vasoactive intestinal peptide-positive (VIP + ) INs expressing Cbln2 (Paul et al., 2017; Tasic et al., 2016) . Therefore, we tested if Cbln2 and Cbln4 regulate the density of inhibitory synapses. To that end, adeno-associated viral vectors (AAVs) carrying an A B C Histogram represents means ± SEM. Data corresponding to shControl, shGluD1, and shGluD1 + GluD1* are the same as in Figure 1G . n shControl = 41, n shGluD1 = 30, n shGluD1 + GuD1 * = 32, n shGluD1 + GluD1 DNTD = 30, n shGluD1 + GluD1 R3341A/W343A = 32, n shGluD1 + GluD1 R526K = 30, n shGluD1 + GluD1 V617R = 29, n shGluD1 + GluD1 DCTD = 28. ns p > 0.05, ***p < 0.001, determined by one-way ANOVA test followed by Tukey's post test.
shRNA directed against Cbln4, Cbln2, or a control shRNA (Figure S1D) were injected in vivo in the lateral ventricles of newborn pups previously electroporated in utero with EGFP-GPHN and tdTomato ( Figures 5A and 5B ). We then quantified the density of gephyrin clusters in sparse electroporated neurons surrounded by numerous infected cells ( Figure 5B ). In juvenile mice, Cbln4, but not Cbln2, inactivation significantly decreased the density of inhibitory synapses (85% ± 4% of control for shCbln4 and 102% ± 4% for shCbln2; Figure 5C ). GluD1 interacted with Cbln4 ( Figure 5D ), and Cbln4 KD did not further decrease the density of gephyrin clusters in grid1 KO neurons (98% ± 5% of Grid1-KO/shCtrl neurons; Figure 5E ), indicating that Cbln4 operates via GluD1. The role of Cbln4 at inhibitory synapses between SST + INs and CPNs has recently been characterized in more detail by Favuzzi et al. (2019) . Taken together, these results indicate that GluD1 specifies inhibitory cortical connectivity by mediating synaptogenesis between Cbln4-expressing SST + INs and CPNs. This is compatible with the partial colocalization of GluD1 and gephyrin ( Figures 3C and 3D ) in oblique apical dendrites, which are also contacted by other classes of interneurons (Fishell and Kepecs, 2019) .
Postsynaptic Signaling Controlling Inhibitory Synapse Formation
To determine the postsynaptic mechanisms through which GluD1 regulates the formation of inhibitory synaptic machineries, we performed an unbiased proteomic screen aimed at identifying GluD1 interacting partners at synapses. We employed subcellular fractionations from P15 mouse brains to enrich our samples in proteins associated with synaptic membranes and efficiently immunoprecipitate GluD1 ( Figure 6A ). The proteins co-immunoprecipitated with GluD1 (gene name Grid1) were separated by liquid chromatography and identified using tandem mass spectrometry (LC-MS/MS) ( Figures 6A and 6B ; Table S1 ). We focused on the proteins that were the most represented in terms of the number of detections in LC-MS/MS biological triplicates relative to their molecular weight. GluD1 was strongly associated with regulators of GTPases (e.g., ARHGEF12 and SRGAP3) and regulators of protein phosphorylation (e.g., the serine/threonine phosphatase 1 regulatory subunit PPP1R12A and the serine/threonine protein kinase MRCKa, encoded cdc42bpa), pointing out the involvement of signaling pathways.
To determine the contribution of these proteins to the development of inhibitory synapses, we manipulated their expression in vivo using IUE. We first investigated the role of ARHGEF12 (also referred to as LARG), a guanine nucleotide exchange factor for RhoA (Chen et al., 1999) . We generated an shRNA against arhgef12 (shArhgef12) and an shRNA-resistant construct (ARHGEF12*; Figure S1B ). In juvenile mice, sparse arhgef12 KD decreased the density of gephyrin clusters to 79% ± 3% of the control value ( Figure 6C ). Normal gephyrin cluster density was rescued by ARHGEF12* (94% ± 3%). These data identify ARHGEF12 as a new determinant of inhibitory synapse formation in the dendrites of CPNs. We next considered the role of Slit-Robo Rho GTPAse-activating proteins (SRGAPs). In LC-MS/MS, GluD1 was associated not only with SRGAP3, but also with SRGAP1 and SRGAP2 (Table S1 ). SRGAP3 and SRGAP2 have previously been shown to interact with gephyrin and regulate the development of inhibitory synapses in the hippocampus and the cortex, respectively Okada et al., 2011) . We found that SRGAP2 inactivation decreases the cell surface expression of GluD1 in young (15 days in vitro), but not older (22-23 days in vitro), neurons ( Figure S4 ), suggesting a developmental regulation of GluD1 trafficking.
We then assayed the role of MRCKa and PPP1R12A, two proteins likely to modulate the phosphorylation state of proteins implicated in building up inhibitory synapses. Neither the overexpression of a kinase-dead dominant-negative mutant of MRCKa (MRCKa KinD, with K106A substitution) (Leung et al., 1998) nor that of wild-type MRCKa (MRCKa WT) affected the density of gephyrin clusters ( Figure 6D ) in juvenile mice, indicating that MRCKa is not critical for the formation of inhibitory synapses. In contrast, depletion of PPP1R12A (also referred to as MYPT1), a targeting subunit of PP1, with shRNAs decreased the density of gephyrin clusters (74% ± 3% of the control), and normal gephyrin cluster density was rescued with the shRNA-resistant mutant PPP1R12A* ( Figure 6E ; Figure S1C ), demonstrating that PPP1R12A is required for the formation of inhibitory synapses in dendrites. These data are in line with a previous study indicating that PP1 physically interacts with gephyrin and regulates the density of gephyrin clusters (Bausen et al., 2010) .
Since both ARHGEF12 and PPP1R12A inactivation mimic GluD1 loss of function, our data suggest that GluD1 might signal through these two proteins to mediate the formation of inhibitory synapses. Using the CRISPR-Cas9 system combined with IUE to inactivate grid1 (Figures 1J and 1K) , ppp1r12a, and arhgef12 ( Figure 6F ), we found that neither grid1/ arhgef12 double KO nor grid1/ppp1r12a double KO further reduced the density of inhibitory synapses compared to single grid1 KO (104% ± 3% of Grid1-KO for Grid1-KO + Ppp1r12a-KO and 105% ± 4% of Grid1-KO for Grid1-KO + Arh-gef12-KO; Figure 6G ), indicating that GluD1 requires ARHGEF12 and PPP1R12A to operate at inhibitory synapses. Interestingly, other major partners of GluD1 ( Figure 6B) , such as the Rho GTPase-activating protein 32 (ARHGAP32/PX-RICS) (Nakamura et al., 2016; Uezu et al., 2016) , SRCIN1 (p140cap) (Alfieri et al., 2017; Russo et al., 2019) , and Ankyrin 3 (Ankyrin G) (Nelson et al., 2018) , have been shown to interact with gephyrin and/or regulate inhibitory synaptogenesis. This supports the notion that GluD1 serves as a signaling hub for the formation and specification of inhibitory synapses ( Figure 6H) , and that the regulation of inhibitory synaptogenesis is a major function of GluD1 in the neocortex.
DISCUSSION
In the present study, we employed sparse in vivo molecular manipulations and proteomic approaches to characterize the role of GluD1 in synaptic development in layer 2/3 pyramidal neurons of the somato-sensory cortex. We demonstrate that GluD1 is a maverick among iGluRs, operating at inhibitory synapses rather than excitatory synapses. GluD1 is necessary for the formation of specific inhibitory synapses along dendrites and regulates GABAergic synaptic transmission accordingly. In the upper layers of the cortex, GluD1 is enriched in the postsynaptic membrane of inhibitory synapses, lateral to the active zone, where it establishes trans-synaptic interactions via Cbln4, an extracellular scaffolding protein secreted by SST + INs (Favuzzi et al., 2019) , which, in turn, binds to presynaptic neurexins (Yuzaki, 2017; Zhong et al., 2017) . When interacting with Cbln4 and binding to glycine or D-serine, GluD1 activates postsynaptic signaling pathways that do not depend on ion flux through its channel, but it involves intracellular interactions via its C-terminal tail, organizing the assembly of inhibitory postsynaptic machineries at contact sites with SST + INs. These interactions involve ARHGEF12 and PPP1R12A, two molecules required for GluD1 function at inhibitory synapses and probably other molecules implicated at GABAergic synapses.
Region-Specific Function of GluD1 at Inhibitory Synapses
Although the repertoire of inhibitory synaptic proteins has recently expanded (Krueger-Burg et al., 2017) , the molecular diversity of inhibitory synapses and the difficulty of investigating their biochemistry and their cell biology in vivo has obscured the mechanistic understanding of inhibitory synaptogenesis. Hence, few CAMs and signaling molecules have been shown to selectively control inhibitory synapse assembly (Krueger-Burg et al., 2017; Tyagarajan and Fritschy, 2014) . These molecules show domain-specific functions at perisomatic (Fr€ uh et al., 2016; Poulopoulos et al., 2009) , dendritic , or axo-axonic synapses (Panzanelli et al., 2011) . Their function also varies depending on brain areas. In particular, extensive studies of neuroligin 2 and collybistin (ARHGEF9), two proteins present in virtually all inhibitory synapses in the CNS, have highlighted fundamental differences between the cell biology of hippocampal and cortical inhibitory synapses (Gibson et al., 2009; Poulopoulos et al., 2009; Papadopoulos et al., 2007) . Since the mechanisms of synaptogenesis in the forebrain are predominantly studied in hippocampal neurons, the molecular underpinning of inhibitory synapse formation in the cortex has remained enigmatic.
Previous in vitro hemi-synapse formation assays suggested a synaptogenic activity of GluD1 in cortical neurons (Ryu et al., 2012; Yasumura et al., 2012) . However, it was unclear whether the synaptogenic activity was selective for inhibitory synapses (Yasumura et al., 2012) or common to excitatory and inhibitory synapses (Ryu et al., 2012) , and the role of endogenous GluD1 in cortical neurons in vivo remained unclear (Gupta et al., 2015) . Here, we used in vivo single cell approaches based on sparse IUE to manipulate GluD1 expression and function in isolated layer 2/3 CPNs in the intact brain. Targeting a specific cell type allowed us to investigate a relatively homogeneous population of neurons and dissect cell-autonomous mechanisms with a subcellular resolution in spatially identified synapses along the dendritic tree. Moreover, sparse in vivo manipulations help avoid compensatory and adaptive changes at the network level, which might occur in KO mouse models. Our results provide direct evidence that GluD1 is necessary for the formation of specific cortical inhibitory synapses in vivo. While we do not exclude that GluD1 could regulate some properties of excitatory synapses in the cortex, we clearly show that GluD1 is not required for their formation, which is consistent with a previous study (Gupta et al., 2015) . Therefore, GluD1 function in CPNs starkly contrasts with GluD1 function in cerebellar INs (Konno et al., 2014) and hippocampal pyramidal neurons (Tao et al., 2018) , where GluD1 is required for the formation of excitatory synapses. This raises fundamental questions on the molecular basis underlying the region-specific function of GluD1 at excitatory or inhibitory synapses and the synaptic dysfunction associated with GluD1 mutations in brain disorders (Cooper et al., 2011; Fallin et al., 2005; Glessner et al., 2009; Guo et al., 2007; Treutlein et al., 2009 ).
An iGluR-Dependent Signaling Pathway at Inhibitory Synapses
It is unconventional for a member of the iGluR family to locate and operate at inhibitory synapses. We show that trans-synaptically engaged GluD1 binding to glycine or D-serine initiates postsynaptic signaling via non-ionotropic mechanisms, probably through conformational changes that are transmitted through the TMD, and controls intracellular interactions (Elegheert et al., 2016) . Whether GluD1 binds to glycine or D-serine in CPNs is unknown, but both glycine and D-serine may contribute to the regulation of inhibitory synapse formation. Glycine is present in the extracellular space, where it activates extrasynaptic NMDA receptors (Papouin et al., 2012) and mediates tonic inhibition in layer 2/3 CPNs (McCracken et al., 2017; Salling and Harrison, 2014) . In the brainstem and spinal cord, where glycine is a major inhibitory neurotransmitter and GluD1 is highly expressed (https://www.gtexportal.org/home/gene/GRID1), presynaptic release of glycine may directly regulate the formation and maintenance of inhibitory synapses. D-serine is also present in the extracellular environment. It is synthesized through conversion of L-serine by serine racemase and released at least by the neuronal alanine-serine-cysteine transporter 1 (Asc-1) (Rosenberg et al., 2013) . Ambient D-serine level is regulated by excitatory glutamatergic activity (Van Horn et al., 2017; Ma et al., 2014) , and low D-serine levels are associated with epilepsy (Klatte et al., 2013) and schizophrenia-like behaviors (Ma et al., 2013) , consistent with defects in synaptic inhibition and GluD1 function. So far, in the forebrain, the role of D-serine and, to some extent, glycine has been envisioned through the activation of NMDA receptors (Oliet and Mothet, 2009 ). The role of GluD1 in establishing the equilibrium between excitation and inhibition and the requirement of GluD1 activation by glycine/D-serine suggests that some functions initially attributed to NMDA receptors might instead depend on GluD1 signaling.
Proteomic and functional analyses of GluD1 interactome allowed us to identify signaling pathways controlling the postsynaptic organization of inhibitory machineries. We found that two major partners of GluD1, ARHGEF12 and PPP1R12A, are necessary for inhibitory synapse formation in layer 2/3 CPNs. Double inactivation experiments showed that ARHGEF12 and PPP1R12A operate in the same pathway as GluD1 and therefore also contribute to the specification of inhibitory connectivity between SST + INs and layer 2/3 CPNs. ARHGEF12 contains a Dbl-homology (DH) domain mediating guanosine diphosphate (GDP)/guanosine triphosphate (GTP) exchange activity and a pleckstrin-homology (PH) domain, which binds phosphoinositides and regulates its membrane targeting (Hyvö nen et al., 1995) . ARHGEF12 also contains an N-terminal PDZ domain, which may interact with the C-terminal PDZ-binding motif of GluD1, and a regulator of G-protein signaling-like (RGSL) domain.
Although further experiments are needed to determine how ARHGEF12 contributes to inhibitory synaptic development, one possibility is that ARHGEF12 links trans-synaptic interaction with phosphoinositide and G-protein signaling to mediate inhibitory synaptogenesis. Furthermore, our data on PPP1R12A suggest that targeting PP1 to GluD1-mediated contact sites between INs and pyramidal neurons and locally regulating the post-translational state of inhibitory synaptic components is critical to initiate or promote postsynaptic assembly. This is congruent with previous studies showing that PP1 associates with gephyrin and the beta-3 subunit of GABA A receptors (GABA A Rs) (Bausen et al., 2010; Pribiag and Stellwagen, 2013) and that pharmacological inhibition of PP1 induces a loss of gephyrin clusters (Bausen et al., 2010) . Among the most represented interactors of GluD1 we identify here, Ankyrin 3, ARHGAP32/PX-RICS, SRCIN1/ p140Cap, and SRGAPs were previously implicated at inhibitory synapses. Ankyrin 3 interacts with GABA A R-associated protein (GABARAP) and contributes to stabilization of GABA A Rs in the postsynaptic membrane (Nelson et al., 2018) . ARHGAP32 interacts with gephyrin, and its inactivation impairs GABA A R trafficking at synapses (Nakamura et al., 2016; Uezu et al., 2016) . SRCIN1, SRGAP3, and SRGAP2 also associate with gephyrin and regulate GABAergic synaptogenesis (Alfieri et al., 2017; Fossati et al., 2016; Okada et al., 2011; Russo et al., 2019) . Therefore, GluD1 trans-synaptic signaling provides local regulation of protein phosphorylation and GTPase activity and allows the recruitment of synaptic molecules for the assembly of inhibitory postsynaptic machineries in an input-specific and agonistdependent manner. Interestingly, in young neurons, GluD1 expression at the cell surface was decreased by SRGAP2 inactivation. SRGAP2, and by homology SRGAP3, is inhibited by the human-specific protein SRGAP2C Coutinho-Budd et al., 2012) . This regulation could contribute to the delay of the development of inhibitory synapses in human neurons and modify inhibitory circuitry to accommodate a greater diversity of IN subtypes (Defelipe, 2011) . Understanding the diversity of trans-synaptic interactions and signaling pathways coordinating the establishment of neocortical inhibitory circuitry, their interplay, their evolution in human, and their dysregulations in brain disorders will be a fertile area for future research.
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